Business / Finance

RSS

Valeant second quarter total revenue increases to record $609.4 million

Valeant Pharmaceuticals International, Inc. announces second quarter financial results for 2011.

4 Aug 2011

Health Net second quarter total revenues decrease 19.2% to $2.8 billion

Health Net, Inc. today announced 2011 second quarter GAAP net income of $58.3 million, or $0.63 per diluted share, compared with $45.1 million, or $0.45 per diluted share, for the second quarter of 2010.

4 Aug 2011

Micromet second quarter total revenues increase to $7.1 million

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

Transcend second quarter revenue increases 38% to $30,662,000

Transcend Services, Inc., a leading provider of clinical documentation solutions to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2011.

4 Aug 2011

SXC second quarter revenue increases 153% to $1.2 billion

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, announces its financial results for the three-month and six-month periods ended June 30, 2011.

4 Aug 2011

Columbia Laboratories second quarter total net revenues increase to $19.2 million

Columbia Laboratories, Inc. today reported financial results for the three- and six-month periods ended June 30, 2011.

4 Aug 2011

CIGNA consolidated revenues increase 7% for second quarter 2011

CIGNA Corporation today reported second quarter 2011 results, that included strong revenue growth and earnings from each of our ongoing businesses, reflecting continued effective execution of the fundamentals supporting our long-term growth strategy.

4 Aug 2011

BioCryst second quarter total revenues decrease to $3.7 million

BioCryst Pharmaceuticals, Inc. announced financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

SynCo Bio commences release of drug products after expansion of Class A zone

SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of its Class A zone.

4 Aug 2011

Prestige Brands Holdings first quarter revenues increase 33.8% to $95.3 million

Prestige Brands Holdings, Inc. today announced results for the first fiscal quarter ended June 30, 2011, including revenues of $95.3 million, an increase of 33.8% over the prior year comparable period's results of $71.2 million.

4 Aug 2011

Eltek receives PCB orders worth $490,000 for use in medical devices

Eltek Ltd., the leading Israeli manufacturer of advanced flex-rigid circuitry solutions, announced today that it has received orders valued at $490,000.

4 Aug 2011

Omega reports operating revenues of $72.6 million for second quarter 2011

Omega Healthcare Investors, Inc. today announced its results of operations for the three- and six-month period ended June 30, 2011.

4 Aug 2011

Diamedix, LABSCO sign distribution agreement for instrumentation systems and test kits

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, announced that Diamedix Corporation, IVAX Diagnostics' wholly-owned subsidiary located in Miami, Florida, has signed a three-year agreement with Laboratory Supply Company, the largest privately held supplier of diagnostic instrumentation and clinical laboratory products to hospitals, physician office laboratories, reference labs and other non-acute care settings in the United States.

4 Aug 2011

ImmunoGen revenues increase to $19.3 million for fiscal year 2011

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for the three-month period and fiscal year ended June 30, 2011.

4 Aug 2011

Par Pharmaceutical reports second quarter total revenues of $224.2 million

Par Pharmaceutical Companies, Inc. today reported results for the second quarter ended June 30, 2011.

3 Aug 2011

SuperGen second quarter net income decreases to $903,000

SuperGen, Inc. today reported financial results for the second quarter ended June 30, 2011. The Company reported net income for the 2011 second quarter of $903,000, or $0.01 per basic and diluted share, compared with $961,000, or $0.02 per basic and diluted share, for the same prior year period.

3 Aug 2011

Celldex second quarter net loss increases to $10.2 million

Celldex Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2011. Celldex reported a net loss of $10.2 million, or $0.27 per share, for the second quarter of 2011 compared to a net loss of $9.5 million, or $0.30 per share, for the second quarter of 2010.

3 Aug 2011